Updates are available Correction dated 2023-11-22
Click to view Correction: https://doi.org/10.1186/s12876-023-03048-z
-
Authors
Pehrsson, Martin
de Rooij, Willemijn E.
Bay-Jensen, Anne-Christine
Karsdal, Morten Asser
Mortensen, Joachim Høg
Bredenoord, Albert Jan
-
Funding
Funding for this research was provided by:
Unrestricted Grant from Gossamer Bio
- License Information
-
More Information
Article History
Received: 29 June 2022
Accepted: 26 September 2023
First Online: 16 October 2023
Change Date: 22 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12876-023-03048-z
Declarations
:
: The Amsterdam University Medical Center Medical Ethics Committee provided an exemption to seek formal approval for this biomarker substudy on 01-08-2019 (W19_295#19.352). All participants provided written informed consent and were given a unique study ID to ensure anonymity. All experiments were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: Conflict of interest: MP and WEdR have no conflict of interest. JHM is employed at Nordic Bioscience A/S. ACBJ and MAK are employed at and own stocks in Nordic Bioscience A/S. AJB has received research funding from Nutricia, Norgine, SST, Thelial, and Bayer; and speaker or consulting fees from Laborie, EsoCap, Medtronic, DrFalk, Calypso Biotech, Regeneron/Sanofi, Celgene, AstraZeneca, and Arena. WEdR and AJB received an unrestricted grant from Gossamer.
